Market Research Logo

MabVax Therapeutics Holdings Inc (MBVX) - Financial and Strategic SWOT Analysis Review

MabVax Therapeutics Holdings Inc (MBVX) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

MabVax Therapeutics Holdings Inc (MabVax Therapeutics) formerly known as Telik, Inc. is a clinical-stage biotechnology company that focuses on development of pipeline of human monoclonal antibody products for diagnosis and treatment of cancer. The company's research and development activities are focused on advancing its clinical advanced drug candidates, under the antibody and vaccine programs. The pipeline product candidates include HuMab-5B1, MVT-5873, MVT-2163, and MVT-1075. The company’s vaccine programs candidates for bivalent vaccine, trivalent vaccine, pentavalent vaccine and multiple vaccines. The company has partnerships with academic institutions and also with pharmaceutical and biotechnology companies. MabVax Therapeutics is headquartered in San Diego, California, the US.

MabVax Therapeutics Holdings Inc Key Recent Developments

May 24,2017: MabVax Therapeutics Reports First Quarter 2017 Operational and Financial Results
Nov 10,2016: MabVax Therapeutics Reports Third Quarter 2016 Financial Results
Aug 03,2016: MabVax Therapeutics Holdings announces development and manufacturing services agreement with Patheon
Jul 18,2016: MabVax Therapeutics Initiates Patient Enrollment in a Phase I Trial for a New Diagnostic Imaging Product for Pancreatic Cancer
Apr 18,2016: MabVax Therapeutics' Fully Human Antibody Approach to Cancer Therapeutics and Imaging Featured in Three Presentations at AACR Annual Meeting in New Orleans

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company 5
MabVax Therapeutics Holdings Inc - Key Facts 5
MabVax Therapeutics Holdings Inc - Key Employees 6
MabVax Therapeutics Holdings Inc - Key Employee Biographies 7
MabVax Therapeutics Holdings Inc - Major Products and Services 8
MabVax Therapeutics Holdings Inc - History 9
MabVax Therapeutics Holdings Inc - Company Statement 11
MabVax Therapeutics Holdings Inc - Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 – Company Analysis 14
MabVax Therapeutics Holdings Inc - Business Description 14
MabVax Therapeutics Holdings Inc - Corporate Strategy 15
MabVax Therapeutics Holdings Inc - SWOT Analysis 16
SWOT Analysis - Overview 16
MabVax Therapeutics Holdings Inc - Strengths 16
MabVax Therapeutics Holdings Inc - Weaknesses 17
MabVax Therapeutics Holdings Inc - Opportunities 18
MabVax Therapeutics Holdings Inc - Threats 19
MabVax Therapeutics Holdings Inc - Key Competitors 20
Section 3 – Company Financial Ratios 21
Financial Ratios - Capital Market Ratios 21
Financial Ratios - Annual Ratios 22
Performance Chart 24
Financial Performance 24
Financial Ratios - Interim Ratios 25
Financial Ratios - Ratio Charts 26
Section 4 – Company’s Lifesciences Financial Deals and Alliances 27
MabVax Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 27
MabVax Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 28
MabVax Therapeutics Holdings Inc, Recent Deals Summary 29
Section 5 – Company’s Recent Developments 30
May 24, 2017: MabVax Therapeutics Reports First Quarter 2017 Operational and Financial Results 30
Nov 10, 2016: MabVax Therapeutics Reports Third Quarter 2016 Financial Results 31
Aug 03, 2016: MabVax Therapeutics Holdings announces development and manufacturing services agreement with Patheon 32
Jul 18, 2016: MabVax Therapeutics Initiates Patient Enrollment in a Phase I Trial for a New Diagnostic Imaging Product for Pancreatic Cancer 33
Apr 18, 2016: MabVax Therapeutics' Fully Human Antibody Approach to Cancer Therapeutics and Imaging Featured in Three Presentations at AACR Annual Meeting in New Orleans 34
Apr 15, 2016: MabVax Therapeutics Holdings Hires Paul Resnick, M.D. as Chief Business Officer 35
Feb 25, 2016: MabVax Therapeutics Holdings Announces New Board Member 36
Section 6 – Appendix 37
Methodology 37
Ratio Definitions 37
About GlobalData 41
Contact Us 41
Disclaimer 41
List of Tables
MabVax Therapeutics Holdings Inc, Key Facts 5
MabVax Therapeutics Holdings Inc, Key Employees 6
MabVax Therapeutics Holdings Inc, Key Employee Biographies 7
MabVax Therapeutics Holdings Inc, Major Products and Services 8
MabVax Therapeutics Holdings Inc, History 9
MabVax Therapeutics Holdings Inc, Subsidiaries 13
MabVax Therapeutics Holdings Inc, Key Competitors 20
MabVax Therapeutics Holdings Inc, Ratios based on current share price 21
MabVax Therapeutics Holdings Inc, Annual Ratios 22
MabVax Therapeutics Holdings Inc, Annual Ratios (Cont...1) 23
MabVax Therapeutics Holdings Inc, Interim Ratios 25
MabVax Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 27
MabVax Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 28
MabVax Therapeutics Holdings Inc, Recent Deals Summary 29
Currency Codes 37
Capital Market Ratios 37
Equity Ratios 38
Profitability Ratios 38
Cost Ratios 39
Liquidity Ratios 39
Leverage Ratios 40
Efficiency Ratios 40
List of Figuress
MabVax Therapeutics Holdings Inc, Performance Chart (2012 - 2016)
MabVax Therapeutics Holdings Inc, Ratio Charts
MabVax Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
MabVax Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report